HBI
58
2
KR
52
2
FAST
42
-2
GOOG
81
-2
NTRS
47
3
CVS
32
3
AAPL
65
-2
AES
49
-2
UNM
70
2
STX
35
-2
MKC
51
-2
CA
32
3
CMA
48
2
KO
44
-2
BAX
41
2
JCI
44
2
PAYX
54
9
HCP
54
-2
R
63
2
NWS
73
-2
HBI
58
2
KR
52
2
FAST
42
-2
GOOG
81
-2
NTRS
47
3
CVS
32
3
AAPL
65
-2
AES
49
-2
UNM
70
2
STX
35
-2
MKC
51
-2
CA
32
3
CMA
48
2
KO
44
-2
BAX
41
2
JCI
44
2
PAYX
54
9
HCP
54
-2
R
63
2
NWS
73
-2
Financhill
Back

Globalstar 10K Form

Buy
68

GSAT
Globalstar

Last Price:
$2.14
Seasonality Move:
22.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GSAT News And Ratings

See the #1 stock for the next 7 days that we like better than GSAT

GSAT Financial Statistics

Sales & Book Value

Annual Sales: $223.8M
Cash Flow: $5.5M
Price / Cash Flow: 0
Annual Sales: $0.21
Price / Book: 10.23

Profitability

EPS (TTM): -0.02480
Net Income (TTM): $-28M
Gross Margin: $154.3M
Return on Equity: -7.31%
Return on Assets: -3.05%

Globalstar Earnings Forecast

Key Globalstar Financial Ratios

  • The Gross Profit Margin over the past 21 years for GSAT is 68.96%.
  • The Selling, General & Administrative Expenses for GSAT have been equal to 29.47% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 407.60% of Operating Income.
  • The Net Earning history of GSAT is -11.04% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Globalstar Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Diversified Telecommunication Services
Sector: Communication Services
Current Symbol: GSAT
CUSIP: 378973
Website: globalstar.com

Debt

Debt-to-Equity Ratio: 1
Current Ratio: 1.09
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GSAT Technical Analysis vs Fundamental Analysis

Buy
68
Globalstar (GSAT) is a Buy

Is Globalstar a Buy or a Sell?

  • Globalstar stock is rated a Buy
    The current Globalstar [GSAT] share price is $2.13. The Score for GSAT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.